Navigation Links
Onyx Pharmaceuticals Files Complaint Against Bayer Corporation
Date:5/17/2009

The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developing and marketing Nexavar(R), a small molecule drug. Nexavar is currently approved for the treatment of liver cancer and advanced kidney cancer. Additionally, Nexavar is being investigated in several ongoing trials in a variety of tumor types. For more information about Onyx, visit the company's website at www.onyx-pharm.com.

Nexavar(R) (sorafenib) tablets is a registered trademark of Bayer HealthCare Pharmaceuticals.

    Contacts:
    Investors                                 Media
    Julie Wood                                Lori Murray
    Vice President, Investor Relations        Associate Director, Corporate
    510-597-6505                              Communications
                                              510-597-6394


'/>"/>
SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Poniard Pharmaceuticals Files Shelf Registration
2. OncoGenex Pharmaceuticals Announces Release of Two ASCO Abstracts: Impact of OGX-011 on Survival in Randomized Phase 2 Trial and Phase 1 Safety Data for OGX-427
3. Vanda Pharmaceuticals to Present Data on Fanapt(TM) and Tasimelteon at the 162nd American Psychiatric Association Annual Meeting
4. Ausio Pharmaceuticals to Present at Bio(R) 2009
5. VIA Pharmaceuticals Announces Complete Enrollment in FDG-PET Phase 2 Study of VIA-2291 in Cardiovascular Patients
6. Poniard Pharmaceuticals to Present at the Leerink Swann Oncology Roundtable Conference
7. Amylin Pharmaceuticals to Present at Deutsche Bank Health Care Conference
8. Poniard Pharmaceuticals to Present at the 2009 BIO International Convention
9. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on First Quarter 2009 Financial Results on Thursday, May 14, 2009 at 8:30am EDT
10. Arena Pharmaceuticals Announces First Quarter 2009 Financial Results
11. Idenix Pharmaceuticals to Present at The Deutsche Bank 2009 Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... ... July 27, 2015 , ... BlueInGreen® announced the addition of ... bring the world’s most efficient gas dissolution technology to all of Florida, excluding ... the industrial and municipal markets. With offices located in Sarasota, Sebring and Melbourne ...
(Date:7/27/2015)... ... July 27, 2015 , ... Visual Assay was named as a finalist for ... innovative technologies and services of the past year. More than 70 judges selected the ... winners will be announced at the 2015 R&D 100 Awards Dinner on November 13 ...
(Date:7/24/2015)... 2015 Equity Research Institute has ... (NASDAQ: PDLI ), Arena Pharmaceuticals Inc. (NASDAQ: ... Biotherapeutics Inc. (NASDAQ: NWBO ), and Acorda Therapeutics ... PDL BioPharma can be accessed at https://www.EquityResearchInstitute.com/reports?keyword=PDLI ... at 5,146.41, down 0.49%, the Dow Jones Industrial Average ...
(Date:7/24/2015)... China , July 24, 2015 ... manufacturing platform , Expands product offering for chronic ... unmet medical needs in diabetes-related complications and dermatology ... 3SBio Inc., (HKEX:1530) ("3SBio" or ,the Company"), a leading ... researching, developing, manufacturing and marketing biopharmaceutical products, today announced ...
Breaking Biology Technology:BlueInGreen Brings Water Treatment Technology to Florida 2Visual Assay® Named Finalist in 53rd Annual R&D 100 Awards 2Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 2Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 3Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 4Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 53SBio Acquires Zhejiang Wansheng Pharmaceutical 23SBio Acquires Zhejiang Wansheng Pharmaceutical 33SBio Acquires Zhejiang Wansheng Pharmaceutical 4
... Reportlinker.com announces that a new market research report ... Gene Therapy - technologies, markets and companies ... Summary Gene therapy can be ... material to specific target cells of a patient ...
... Nov. 30, 2011  Rhythm announced today that Lex Van ... Scientific Officer. Dr. Van der Ploeg brings to Rhythm ... obesity, metabolic diseases, and other therapeutic areas. ... of the metabolic pathways we are targeting with our ...
... 2011 Reportlinker.com announces that a new ... catalogue: Animal Biotechnology - ... http://www.reportlinker.com/p0203534/Animal-Biotechnology---Technologies-Markets-and-Companies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biotechnology Summary ... evaluates animal biotechnology and its application in ...
Cached Biology Technology:Gene Therapy - Technologies, Markets and Companies 2Gene Therapy - Technologies, Markets and Companies 3Gene Therapy - Technologies, Markets and Companies 4Gene Therapy - Technologies, Markets and Companies 5Gene Therapy - Technologies, Markets and Companies 6Gene Therapy - Technologies, Markets and Companies 7Gene Therapy - Technologies, Markets and Companies 8Gene Therapy - Technologies, Markets and Companies 9Gene Therapy - Technologies, Markets and Companies 10Gene Therapy - Technologies, Markets and Companies 11Gene Therapy - Technologies, Markets and Companies 12Gene Therapy - Technologies, Markets and Companies 13Gene Therapy - Technologies, Markets and Companies 14Gene Therapy - Technologies, Markets and Companies 15Gene Therapy - Technologies, Markets and Companies 16Gene Therapy - Technologies, Markets and Companies 17Gene Therapy - Technologies, Markets and Companies 18Gene Therapy - Technologies, Markets and Companies 19Gene Therapy - Technologies, Markets and Companies 20Gene Therapy - Technologies, Markets and Companies 21Rhythm Names Lex Van der Ploeg Chief Scientific Officer 2Animal Biotechnology - Technologies, Markets and Companies 2Animal Biotechnology - Technologies, Markets and Companies 3Animal Biotechnology - Technologies, Markets and Companies 4Animal Biotechnology - Technologies, Markets and Companies 5Animal Biotechnology - Technologies, Markets and Companies 6Animal Biotechnology - Technologies, Markets and Companies 7Animal Biotechnology - Technologies, Markets and Companies 8Animal Biotechnology - Technologies, Markets and Companies 9Animal Biotechnology - Technologies, Markets and Companies 10Animal Biotechnology - Technologies, Markets and Companies 11Animal Biotechnology - Technologies, Markets and Companies 12Animal Biotechnology - Technologies, Markets and Companies 13Animal Biotechnology - Technologies, Markets and Companies 14
(Date:7/23/2015)... DUBLIN , July 23, 2015 ... the addition of the "Global Outlook of ... their offering. The global biometrics ... both public and commercial applications owing to the ... will witness a transformation that enhances the growth ...
(Date:7/20/2015)... , July 20, 2015  Acuity Market Intelligence,s ... The Convergence of Commerce and Privacy" forecasts that ... biometric apps will be downloaded to smart mobile ... mobile biometrics market is projected to generate more ... during the seven-year forecast period.    ...
(Date:7/9/2015)... , July 07, 2015 ... the addition of the "Biometrics for Banking; ... 2015-2020" report to their offering. ... contributor to this growth and the forecast is ... in revenue for companies involved in delivering biometric ...
Breaking Biology News(10 mins):Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3
... good, but sometimes its better to be lucky. Ecologist ... St. Louis, had just completed a census of snakes at ... flood of 1993 deluged the area, putting the preserve at ... with a rare opportunity: His collected data and the flood ...
... have developed tools to help solve two of the main ... to quickly test stem cell response to different drugs or ... viable stem cells to study from only a few available ... of stems cells on devices the size of a standard ...
... several repeat operations as they grow, since the since ... for bigger ones. Researchers at Childrens Hospital Boston have ... the lab from a patients own cells. In ... describe making pulmonary valves through tissue engineering. These valves, ...
Cached Biology News:Ecologist finds dire devastation of snake species following floods of '93, '95 2Ecologist finds dire devastation of snake species following floods of '93, '95 3Ecologist finds dire devastation of snake species following floods of '93, '95 4Putting stem cell research on the fast track 2Putting stem cell research on the fast track 3Putting stem cell research on the fast track 4A step toward tissue-engineered heart structures for children 2
One-step, microplate or cuvet, colorimetric, detection range 0.3 g/dL to 5 g/dL. Procedure: 5 min....
The Varian 4000 GC/MS system offers three easily switchable ionization configurations: internal ionization (II), external ionization (EI) or hybrid chemical ionization (CI)...
One-step, microplate or cuvet, colorimetric, detection range 0.04% to 4%. Procedure: 30 min....
One-step, microplate or cuvet, colorimetric, linear detection range 0.7 mg/dL to 35 mg/dL. Procedure: 5 min....
Biology Products: